Swiss stocks - Factors to watch on June 25
25/06/2015 06:10
ZURICH, June 25 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Thursday
COMPANY STATEMENTS CPR-CH
* Actelion ATLN.VX said data on multiple sclerosis drug
ponesimod showing that the cardiodynamic first-dose effects of
the drug are mitigated by the new gradual up-titration will be
presented at a drug conference in Madrid this week. ATLN.VX
* Newron NWRN.S said it has received a positive opinion
for its New Chemical Entity Sarizotan for the treatment of Rett
Syndrome from the Committee for Orphan Medicinal Products from
the European Medicines Agency. An application for Orphan
Designation has also been filed in the US. NRWN.S
* Carlo Gavazzi GAV.S said full-year net income rose
nearly 10 percent on the year to 12.3 million Swiss francs
($13.18 million) despite a 2 percent fall in revenue and said it
expects the strong franc to hurt revenues. GAV.S
* Lem LEHN.S said it is naming Heinz Stuebi interim Chief
Financial Officer until the new CFO, Andrea Borla, takes on the
role in November. LEHN.S
ECONOMY M-CH
Swiss National Bank head Thomas Jordan speaks in Lausanne
($1 = 0.9332 Swiss francs)
(Reporting by Zurich newsroom)
((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))